Accuracy of combined GDx-VCC and matrix FDT in a glaucoma screening trial

Journal of Glaucoma

Volumn 16, Issue 5, 2007, Pages 462-470

  Tóth, Márta ^a   Kóthy, Péter ^a   Vargha, Péter ^a   Holló, Gábor ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NONE   (Hungary)

Author keywords

Frequency doubling technology; GDx VCC; Glaucoma; Scanning laser polarimetry; Screening

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; PERIMETRY; POLARIMETRY; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FALSE POSITIVE REACTIONS; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; LASERS; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; NERVE FIBERS; OPTIC DISK; OPTIC NERVE DISEASES; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETINAL GANGLION CELLS; SENSITIVITY AND SPECIFICITY;

EID: 34547864189     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3180316754     Document Type: Article

References (53)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
2. Heijl A, Leske MC, Bengtsson B, et al., for the Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268-1279.
3. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
4. Wong EYH, Keeffe JE, Rait JL, et al. Detection of undiagnosed glaucoma by eye health professionals. Ophthalmology. 2004;111:1508-1514.
5. Quigley HA, Park CK, Tracey PA, et al. Community screening for eye disease by laypersons: the Hoffberger Program. Am J Ophthalmol. 2002;133:386-392.
6. Wilson MR. Screening paradigms in glaucoma. J Glaucoma. 2001;10(suppl 1):S25-S27.
7. The Eye Diseases Prevalence Research Group. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122:532-538.
8. Bonomi L, Marchini G, Marraffa M, et al. Prevalence of glaucoma and intraocular pressure distribution in a defined population: The Egna-Neumarkt Study. Ophthalmology. 1998;105:209-215.
9. Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma: the baltimore eye survey. JAMA. 1991;266:369-374.
10. Wolfs RCW, Borger PH, Ramrattan RS, et al. Changing views on open-angle glaucoma: definitions and prevalences - The Rotterdam study. Invest Ophthalmol Vis Sci. 2000;41:3309-3321.
11. Antón A, Andrada MT, Mujica V, et al. Prevalence of primary open-angle glaucoma in a Spanish population: the Segovia study. J Glaucoma. 2004;13:371-376.
12. Nizankowska MH, Kaczmarek R. Prevalence of glaucoma in the Wroclaw population. The Wroclaw epidemiological study. Ophthalmic Epidemiol. 2005;12:363-371.
13. Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet. 2002;359:881-884.
14. Mansberger SL, Johnson CA, Cioffi GA, et al. Predictive value of frequency doubling technology perimetry for detecting glaucoma in a developing country. J Glaucoma. 2005;14:128-134.
15. Detry-Morel M, Zeyen T, Kestelyn P, et al, and the Belgian Glaucoma Society. Screening for glaucoma in a general population with the non-mydriatic fundus camera and the frequency doubling perimeter. Eur J Ophthalmol. 2004;14:387-393.
16. Sanchez-Galeana C, Bowd C, Blumenthal EZ, et al. Using optical imaging summary data to detect glaucoma. Ophthalmology. 2001;108:1812-1818.
17. Harasymowycz PJ, Papamatheakis DG, Fansi AK, et al. Validity of screening for glaucomatous optic nerve damage using confocal scanning laser ophthalmoscopy (Heidelberg Retina Tomograph II) in high-risk populations: a pilot study. Ophthalmology. 2005;112:2164-2171.
18. Medeiros FA, Zangwill LM, Bowd C, et al. Influence of disease severity and optic disc size on the diagnostic performance of imaging instruments in glaucoma. Invest Ophthalmol Vis Sci. 2006;47:1008-1015.
19. Quigley HA, Jampel HD. How are glaucoma patients identified? J Glaucoma. 2003;12:451-455.
20. Harper R, Henson D, Reeves BC. Appraising evaluations of screening/diagnostic tests: the importance of the study populations. Br J Ophthalmol. 2000;84:1198-1202.
21. Medeiros FA, Zangwill LM, Bowd C, et al. Comparison of the GDx VCC scanning laser polarimeter, HRT II confocal scanning laser ophthalmoscope, and Stratus OCT optical coherence tomograph for the detection of glaucoma. Arch Ophthalmol. 2004;122:827-837.
22. Paczka JA, Friedman DS, Quigley HA, et al. Diagnostic capabilities of frequency-doubling technology, scanning laser polarimetry, and nerve fiber layer photographs to distinguish glaucomatous damage. Am J Ophthalmol. 2001;131:188-197.
23. Bowd C, Zangwill LM, Berry CC, et al. Detecting early glaucoma by assessment of retinal nerve fiber layer thickness and visual function. Invest Ophthalmol Vis Sci. 2001;42:1993-2003.
24. Wadood AC, Azuara-Blanco A, Aspinall P, et al. Sensitivity and specificity of frequency-doubling technology, tendency-oriented perimetry, and Humphrey Swedish Interactive Threshold Algorithm-fast perimetry in a glaucoma practice. Am J Ophthalmol. 2002;133:327-332.
25. Fogagnolo P, Mazzolani F, Rossetti L, et al. Detecting glaucoma with frequency-doubling technology perimetry. J Glaucoma. 2005;14:485-491.
26. Cello KE, Nelson-Quigg JM, Johnson CA. Frequency doubling technology perimetry for detection of glaucomatous visual field loss. Am J Ophthalmol. 2000;129:314-322.
27. Trible JR, Schultz RO, Robinson JC, et al. Accuracy of glaucoma detection with frequency-doubling perimetry. Am J Ophthalmol. 2000;129:740-745.
28. Yamada N, Chen P, Mills RP, et al. Screening for glaucoma with frequency-doubling technology and Damato campimetry. Arch Ophthalmol. 1999;117:1479-1484.
29. Thomas R, Bhat S, Muliyil JP, et al. Frequency doubling perimetry in glaucoma. J Glaucoma. 2002;11:46-50.
30. Heeg GP, Stoutenbeek R, Jansonius NM. Strategies for improving the diagnostic specificity of the frequency doubling perimeter. Acta Ophthalmol Scand. 2005;83:53-56.
31. Spry PGD, Hussin HM, Sparrow JM. Clinical evaluation of frequency doubling technology perimetry using the Humphrey Matrix 24-2 threshold strategy. Br J Ophthalmol. 2005;89:1031-1035.
32. Reus NJ, Lemij HG. Diagnostic accuracy of the GDx VCC for glaucoma. Ophthalmology. 2004;111:1860-1865.
33. Da Pozzo S, Iacono P, Marchesan R, et al. Scanning laser polarimetry with variable cornea compensation and detection of glaucomatous optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2005;243:774-779.
34. Choplin NT, Lundy DC. The sensitivity and specificity of scanning laser polarimetry in the detection of glaucoma in a clinical setting. Ophthalmology. 2001;108:899-904.
35. Reus NJ, Lemij HG. Scanning laser polarimetry of the retinal nerve fiber layer in perimetrically unaffected eyes of glaucoma patients. Ophthalmology. 2004;111:2199-2203.
36. Heeg GP, Blanksma LJ, Hardus PLLJ, et al. The groningen longitudinal glaucoma study. I. baseline sensitivity and specificity of the frequency doubling perimeter and the GDx nerve fibre analyser. Acta Ophthalmol Scand. 2005;83:46-52.
37. Horn FK, Nguyen NX, Mardin CY, et al. Combined use of frequency doubling perimetry and polarimetric measurements of retinal nerve fiber layer in glaucoma detection. Am J Ophthalmol. 2003;135:160-168.
38. Iwasaki A, Sugita M, for the Glaucoma Screening Project (GSP) Study Group. Performance of glaucoma mass screening with only a visual field test using frequency-doubling technology perimetry. Am J Ophthalmol. 2002;134:529-537.
39. Brusini P, Salvetat ML, Zeppieri M, et al. Frequency doubling technology perimetry with the Humphrey Matrix 30-2 test. J Glaucoma. 2006;15:77-83.
40. Shah NN, Bowd C, Medeiros F, et al. Combining structural and functional testing for detection of glaucoma. Ophthalmology. 2006;113:1593-1602.
41. European Glaucoma Society. Terminology and Guidelines for Glaucoma. 2nd ed. DOGMA: s.r.l. Savona; 2003.
42. Mills RP, Budenz DL, Lee PP, et al. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol. 2006;141:24-30.
43. Tóh M, Holló G. Enhanced corneal compensation for scanning laser polarimetry on eyes with atypical polarization pattern. Br J Ophthalmol. 2005;89:1139-1142.
44. Johnson CA, Gunvant P, Fingeret M, et al. A Primer for Frequency Doubling Technology (FDT) Perimetry Using the Humphrey Matrix. Zeiss: Welch-Allyn; 2004.
45. Casson RJ, James B. Effect of cataract on frequency doubling perimetry in the screening mode. J Glaucoma. 2006;15:23-25.
46. Tanna AP, Abraham C, Lai J, et al. Impact of cataract on the results of frequency-doubling technology perimetry. Ophthalmology. 2004;111:1504-1507.
47. Joson PJ, Kamantigue MEG, Chen PP. Learning effects among perimetric novices in frequency doubling technology perimetry. Ophthalmology. 2002;109:757-760.
48. Iester M, Capris P, Pandolfo A, et al. Learning effect, short-term fluctuation, and long-term fluctuation in frequency doubling technique. Am J Ophthalmol. 2000;130:160-164.
49. Grodum K, Heijl A, Bengtsson B. A comparison of glaucoma patients identified through mass screening and in routine clinical practice. Acta Ophthalmol Scand. 2002;80:627-631.
50. Lopes de Faria JM, Russ H, Costa VP. Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy. Br J Ophthalmol. 2002;86:725-728.
51. Hirokazu T, Goto T, Shoji T, et al. Diabetes-associated retinal nerve fiber damage evaluated with scanning laser polarimetry. Am J Ophthalmol. 2006;142:88-94.
52. Realini T, Lai MQ, Barber L. Impact of diabetes on glaucoma screening using frequency-doubling perimetry. Ophthalmology. 2004;111:2133-2136.
53. Kook MS, Cho H, Seong M, et al. Scanning laser polarimetry using variable corneal compensation in the detection of glaucoma with localized visual field defects. Ophthalmology. 2005;112:1970-1978.